Involvement of MicroRNAs in Diabetes and Its Complications

Bin Wu1, Daniel Miller2

  • 1Department of Endocrinology, First Affiliated Hospital, Kunming Medical University, 295 Xichang Rd., Wuhua Qu, Kunming, Yunnan, 650031, China. wu.bin.kmu@qq.com.

Insights

MicroRNAs (miRNAs) are crucial in diabetes pathogenesis and complications. Targeting miRNA expression offers a promising therapeutic strategy for this chronic metabolic disease.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genetics

Background:

  • Diabetes mellitus is a global health crisis characterized by hyperglycemia.
  • Its development involves complex genetic and environmental factors affecting insulin.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in diabetes.

Purpose of the Study:

  • To explore the dysregulation of miRNAs in pancreatic islet function.
  • To investigate miRNA roles in insulin action and signaling in peripheral tissues.
  • To discuss the involvement of miRNAs in diabetic complications.

Main Methods:

  • Review of current literature on miRNA involvement in diabetes.
  • Analysis of miRNA regulatory networks in insulin production and secretion.
  • Examination of miRNA impact on insulin signaling pathways.

Main Results:

  • Specific miRNAs are dysregulated in type 1 and type 2 diabetes.
  • These miRNAs affect insulin production, secretion, and peripheral insulin action.
  • miRNA dysregulation contributes significantly to diabetic complications.

Conclusions:

  • MicroRNAs are key players in the pathogenesis and progression of diabetes.
  • Modulating miRNA expression presents a potential therapeutic avenue.
  • Further research into miRNA-based treatments could revolutionize diabetes care.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K